Jean-Sebastien Frenel

Articles by Jean-Sebastien Frenel

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE

BySherene Loi, MD, PhD,Erica Stringer-Reasor,Jean-Sebastien Frenel,Mattea Reinisch,Ruth M. O’Regan,Michelino De Laurentiis,Yeon Hee Park,Anne O’Dea,Yen-Shen Lu,Valeria Gonzalez,Melissa Gao,Sorcha Waters,Huilin Hu,Binghe Xu

June 24th 2025

Latest Updated Articles

22 Efficacy and Safety of Ribociclib + Nonsteroidal Aromatase Inhibitor in Younger Patients With HR+/HER2− Early Breast Cancer in NATALEE
June 24th 2025

Trending on CancerNetwork

FDA Approves sNDA for Taletrectinib in TKI-Naive Advanced ROS1+ NSCLC

IASO208 Receives FDA IND Clearance for Relapsed/Refractory B-Cell Lymphoma

SOHO 2026: Key Updates Across the Multiple Myeloma Continuum

PALOMA-2 Shows Improved Survival vs Historical IV Amivantamab Data

Secondary T-Cell Malignancies: Identifying and Counseling After CAR T-Cell Therapy